SCHEMBL2344202

SCHEMBL2344202

COc1ccc(-c2oc3c(OC)c(OC)cc(O)c3c(=O)c2OC)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.65
MAPT P10636 2/20 0.65
ALDH1A1 P00352 1/20 0.65
MAPK1 P28482 1/20 0.65
CYP2D6 P10635 1/20 0.65
ALOX5 P09917 2/20 0.64
TUBB4A P04350 2/20 0.61
TUBB P07437 2/20 0.61
TUBA3C P0DPH7 2/20 0.61
TUBA1B P68363 2/20 0.61
TUBA4A P68366 2/20 0.61
TUBB4B P68371 2/20 0.61
TUBB3 Q13509 2/20 0.61
TUBB2A Q13885 2/20 0.61
TUBB8 Q3ZCM7 2/20 0.61
TUBA3E Q6PEY2 2/20 0.61
TUBA1A Q71U36 2/20 0.61
TUBA1C Q9BQE3 2/20 0.61
TUBB6 Q9BUF5 2/20 0.61
TUBB2B Q9BVA1 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tambulin SCHEMBL4742083 0.91 ALDH1A1 (0.64) CYP3A4MAPTALDH1A1MAPK1ALOX5
Tambulin SCHEMBL29728591 0.91 ALDH1A1 (0.64) CYP3A4MAPTALDH1A1MAPK1ALOX5
SCHEMBL30819242 0.88 KDM4E (0.74) MAPTALOX5TUBB4ATUBBTUBA3C
Ternatin SCHEMBL1304220 0.88 ALOX5 (0.71) MAPTALOX5TUBB4ATUBBTUBA3C
SCHEMBL1764425 0.88 KDM4E (0.74) MAPTALOX5TUBB4ATUBBTUBA3C
Ternatin SCHEMBL30731678 0.88 ALOX5 (0.71) MAPTALOX5TUBB4ATUBBTUBA3C
SCHEMBL29934461 0.83 ADORA3 (0.64) CYP3A4MAPTALDH1A1MAPK1CYP2D6
SCHEMBL24994535 0.82 ABCB1 (0.65) CYP3A4MAPTCYP2D6ALOX5TUBB4A
SCHEMBL16894648 0.82 ABCG2 (0.66) CYP3A4MAPTALDH1A1MAPK1ALOX5
Prudomestin SCHEMBL30977124 0.81 ABCB1 (0.65) CYP3A4MAPTALDH1A1CYP2D6TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118121649-A Citrus extract, compound, and use thereof for inhibiting novel coronaviruses 丰苗生物科技股份有限公司 2024-06-04 CN claimed
JP-2009506057-A 2009-02-12 JP claimed
EP-1928480-A2 METHODS FOR MANAGING ADIPOCYTE FAT ACCUMULATION Wellgen, Inc. (US) 2008-06-11 EP claimed
WO-2007024982-A2 METHODS FOR MANAGING ADIPOCYTE FAT ACCUMULATION WELLGEN, INC. (US) 2007-03-01 WO claimed
CN-118121649-A Citrus extract, compound, and use thereof for inhibiting novel coronaviruses 丰苗生物科技股份有限公司 2024-06-04 CN disclosed
US-8007836-B2 Cleome spinosa extract used in pharmaceutical preparations and cosmetic compositions PIERRE FABRE DERMO-COSMETIQUE (FR) 2011-08-30 US disclosed
US-20100119632-A1 CLEOME SPINOSA EXTRACT USED IN PHARMACEUTICAL PREPARATIONS AND COSMETIC COMPOSITIONS PIERRE FABRE DERMO-COSMETIQUE (FR) 2010-05-13 US disclosed
EP-1928480-A2 METHODS FOR MANAGING ADIPOCYTE FAT ACCUMULATION Wellgen, Inc. (US) 2008-06-11 EP disclosed
WO-2007024982-A2 METHODS FOR MANAGING ADIPOCYTE FAT ACCUMULATION WELLGEN, INC. (US) 2007-03-01 WO disclosed